← Browse by Condition
Medical Condition
b cell non hodgkin lymphoma
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2, Phase 1, Phase 2, Phase 3
NCT05702853 Phase 1, Phase 2
Recruiting
Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL
Enrollment
27 pts
Location
United States
Sponsor
Medical University of South Ca...
NCT05432635 Phase 1
Recruiting
Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma
Enrollment
15 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT06725524 Phase 1
Recruiting
A Study of JMT601 in Participants With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin Lymphoma
Enrollment
186 pts
Location
China
Sponsor
Shanghai JMT-Bio Inc.
NCT05991388 Phase 2, Phase 3
Recruiting
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Enrollment
210 pts
Location
Australia, Austria, ...
Sponsor
University of Birmingham